{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:37:11Z","timestamp":1782563831111,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T00:00:00Z","timestamp":1496448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SCORE","award":["SC3GM116698"],"award-info":[{"award-number":["SC3GM116698"]}]},{"name":"SCORE","award":["NIGM-RISE R25GM061838."],"award-info":[{"award-number":["NIGM-RISE R25GM061838."]}]},{"name":"RCMI","award":["G12MD007600"],"award-info":[{"award-number":["G12MD007600"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.05.091","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T10:46:38Z","timestamp":1497696398000},"page":"6007-6014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge"],"prefix":"10.1016","volume":"35","author":[{"given":"Osmarie","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Bravo Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saritza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Shisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.vaccine.2017.05.091_b0005","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0264-410X(02)00028-2","article-title":"Smallpox vaccination techniques; from knives and forks to needles and pins","volume":"20","author":"Baxby","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.091_b0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States strategic national stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3121\/cmr.1.2.85","article-title":"Bioterrorism preparedness: the smallpox vaccine debate","volume":"1","author":"Qutaishat","year":"2003","journal-title":"Clin Med Res"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0020","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"issue":"32","key":"10.1016\/j.vaccine.2017.05.091_b0025","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.vaccine.2004.10.052","article-title":"Reactions to small pox vaccine in naive and previously-vaccinated individuals","volume":"23","author":"Auckland","year":"2005","journal-title":"Vaccine"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2017.05.091_b0030","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"17","key":"10.1016\/j.vaccine.2017.05.091_b0035","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.091_b0040","unstructured":"CDC. Smallpox Vaccine [Available from: https:\/\/emergency.cdc.gov\/agent\/smallpox\/vaccination\/vaccine.asp]."},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.091_b0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0264-410X(96)00260-5","article-title":"Development of a multicomponent candidate vaccine for HIV-1","volume":"15","author":"Kim","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.091_b0050","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/427265","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge","volume":"191","author":"Edghill-Smith","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.091_b0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/374716","article-title":"Smallpox vaccination and the patient with an organ transplant","volume":"36","author":"Dropulic","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.091_b0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1034\/j.1600-6143.2003.00145.x","article-title":"Smallpox and live-virus vaccination in transplant recipients","volume":"3","author":"Fishman","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2017.05.091_b0065","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Ann Rev Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2017.05.091_b0070","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1096\/fasebj.12.15.1611","article-title":"Modulating the immune response to genetic immunization","volume":"12","author":"Cohen","year":"1998","journal-title":"Faseb J"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.091_b0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/BC.2001.068","article-title":"Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen","volume":"382","author":"Schirmbeck","year":"2001","journal-title":"Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.091_b0080","first-page":"254","article-title":"DNA vaccines for prostate cancer","volume":"8","author":"McNeel","year":"2012","journal-title":"Curr Cancer Ther Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2017.05.091_b0085","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.05.091_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.05.091_b0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1423-0410.2000.tb00037.x","article-title":"DNA vaccines","volume":"78","author":"Reimann","year":"2000","journal-title":"Vox sanguinis."},{"issue":"9112","key":"10.1016\/j.vaccine.2017.05.091_b0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(97)09440-3","article-title":"Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients","volume":"351","author":"Calarota","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.091_b0105","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.163.4.2330","article-title":"Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment","volume":"163","author":"Calarota","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response","volume":"178","author":"MacGregor","year":"1998","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.091_b0115","doi-asserted-by":"crossref","first-page":"e0123113","DOI":"10.1371\/journal.pone.0123113","article-title":"Immunomodulator-based enhancement of anti smallpox immune responses","volume":"10","author":"Martinez","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.091_b0120","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1128\/IAI.73.9.5666-5674.2005","article-title":"Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B","volume":"73","author":"Ko","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.091_b0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/088922203769232610","article-title":"Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice","volume":"19","author":"Gao","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.091_b0130","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.091_b0135","unstructured":"Administration FaD. ACAM2000 (Smallpox Vaccine) Questions and Answers 2013 [Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/QuestionsaboutVaccines\/ucm078]."},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4049\/jimmunol.164.1.208","article-title":"Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers","volume":"164","author":"Slifka","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"31","key":"10.1016\/j.vaccine.2017.05.091_b0160","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/j.vaccine.2010.05.023","article-title":"Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection","volume":"28","author":"Rudraraju","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.091_b0165","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1101\/gr.1485203","article-title":"Hierarchy of sequence-dependent features associated with prokaryotic translation","volume":"13","author":"Lithwick","year":"2003","journal-title":"Genome Res"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.091_b0170","doi-asserted-by":"crossref","first-page":"e7002","DOI":"10.1371\/journal.pone.0007002","article-title":"Design parameters to control synthetic gene expression in Escherichia coli","volume":"4","author":"Welch","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.091_b0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11693-010-9062-3","article-title":"The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization","volume":"4","author":"Raab","year":"2010","journal-title":"Syst Synth Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.091_b0180","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/JVI.76.4.1649-1662.2002","article-title":"Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G\/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system","volume":"76","author":"Lee","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00329851","article-title":"Intraplasmid recombination in Streptomyces lividans 66","volume":"209","author":"Chen","year":"1987","journal-title":"Mol Gen Genet"},{"issue":"15","key":"10.1016\/j.vaccine.2017.05.091_b0190","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1073\/pnas.111008398","article-title":"Instability of repetitive DNA sequences: the role of replication in multiple mechanisms","volume":"98","author":"Bzymek","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5924","key":"10.1016\/j.vaccine.2017.05.091_b0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.1170160","article-title":"Coding-sequence determinants of gene expression in Escherichia coli","volume":"324","author":"Kudla","year":"2009","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.091_b0200","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2017.05.091_b0205","unstructured":"Klimpel GR. Immune Defenses. In: Baron S, editor. Medical microbiology, 4th ed. Galveston (TX); 1996."},{"key":"10.1016\/j.vaccine.2017.05.091_b0210","series-title":"Immune response to viruses: cell-mediated immunity. Encyclopedia of virology","first-page":"70","author":"Zajac","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4(+) T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.091_b0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1471-4906(01)01975-5","article-title":"Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways","volume":"22","author":"Jankovic","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2017.05.091_b0225","doi-asserted-by":"crossref","unstructured":"Mayya V, Dustin ML. What scales the T cell response? Trends in Immunology 37(8): 513\u201322.","DOI":"10.1016\/j.it.2016.06.005"},{"issue":"11","key":"10.1016\/j.vaccine.2017.05.091_b0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nri3905","article-title":"Sizing up the key determinants of the CD8(+) T cell response","volume":"15","author":"Tscharke","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.091_b0235","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.4049\/jimmunol.163.7.3735","article-title":"The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained","volume":"163","author":"Wherry","year":"1999","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.091_b0240","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.168.9.4455","article-title":"Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope","volume":"168","author":"Wherry","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.091_b0255","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2017.05.091_b0260","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.091_b0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0270","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.3.2.119","article-title":"Recombivax-HB: perspectives past, present and future","volume":"3","author":"Venters","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.091_b0275","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.091_b0280","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4161\/hv.29532","article-title":"Sustained efficacy, immunogenicity, and safety of the HPV-16\/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination","volume":"10","author":"Naud","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.091_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","article-title":"Preclinical and clinical safety studies on DNA vaccines","volume":"2","author":"Schalk","year":"2006","journal-title":"Hum Vaccin"},{"issue":"4\u20136","key":"10.1016\/j.vaccine.2017.05.091_b0290","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000053993","article-title":"Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice","volume":"43","author":"Ledwith","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.05.091_b0295","first-page":"261","article-title":"DNA vaccines: safety aspect assessment and regulation","volume":"126","author":"Medjitna","year":"2006","journal-title":"Dev Biol (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:48:38Z","timestamp":1750358918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":59,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17307612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}